North America Medical Injection Molding Market Report 2031 by Segments, Geography, Dynamics, Recent Developments, and Strategic Insights

The North America Medical Injection Molding Market size is expected to reach US$ 2,745.5 Million by 2031 from US$ 2,016.8 Million in 2024. The market is estimated to record a CAGR of 4.5% from 2024 to 2031.

Executive Summary and North America Medical Injection Molding Market Analysis:

The medical injection moulding market in North America is segmented into the US, Canada, and Mexico. The region's robust healthcare infrastructure and increasing demand for high-quality medical devices, such as syringes, catheters, and diagnostic tools, are several key factors driving the market's growth. Additionally, advancements in medical technologies and the rise in chronic diseases require precise, cost-effective manufacturing processes like injection moulding. The growing adoption of minimally invasive surgeries and personalized medicine further fuels the need for innovative, high-performance medical products in the North American market.

North America Medical Injection Molding Market: Strategic Insights

North America Medical Injection Molding Market Segmentation Analysis:

• By Material, the North America Medical Injection Molding Market is segmented into Polyvinyl Chloride (PVC), Poly(methyl methacrylate) (PMMA), Polyether Ether Ketone (PEEK), Metals, and Others. Others held the largest share of the market in 2024.
• By Type, the North America Medical Injection Molding Market is segmented into Plastic Injection Molding, Overmolding, Liquid Silicone Molding, and Others. Plastic Injection Molding held the largest share of the market in 2024.
• By End User, the North America Medical Injection Molding Market is segmented into Medical Devices Companies, Pharmaceutical Drug Packaging Companies, Surgical Instruments Companies, and Others. Medical Devices Companies held the largest share of the market in 2024.
• By Product Type, the North America Medical Injection Molding Market is segmented into Medical Equipment Components, Consumables, Patient Aids, Orthopedic Instruments, Dental Products, and Others. Medical Equipment Components held the largest share of the market in 2024.
• By System, the North America Medical Injection Molding Market is segmented into Hot Runner and Cold Runner. Hot Runner held the largest share of the market in 2024.

North America Medical Injection Molding Market Players Density: Understanding Its Impact on Business Dynamics

The North America Medical Injection Molding Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Medical Injection Molding Market Outlook

Advancements such as all-electric injection moulding and micro-moulding have made a big difference in the production of medical devices, thereby fueling the overall medical injection moulding market progress. All-electric machines are especially valuable for their energy efficiency and precise control, which are essential when manufacturing high-quality medical components. These machines can operate compatibly in cleanroom environments, ensuring contamination-free output that meets strict hygiene standards. Micro-moulding, on the other hand, allows for the creation of incredibly small and precise parts, which is crucial for producing miniature medical devices such as implants and diagnostic tools. Together, these innovations are improving manufacturing processes, reducing waste, and making it easier to maintain the high standards required for medical devices.

Several companies, including MTD Micro Moulding, Makuta Technics Inc., Accumold, Sungplastic, and WestFall Technik, have made significant advancements in injection moulding technologies, particularly in all-electric machines and micro-moulding, to enhance the precision, efficiency, and cleanliness of the medical device manufacturing process. In 2021, MTD Micro Moulding celebrated the grand opening of its expanded medical micro injection moulding facility. This expansion was designed to accommodate the burgeoning demand for ultra-precision molded components in the medical device industry. In April 2021, Tederic Machinery Co. launched the NEO series of electric, hybrid injection moulding machines. These machines feature a new generation of servo pumps, enabling energy savings of up to 80% compared to traditional hydraulic machines. Additionally, in September 2020, ENGEL introduced e-speed injection moulding machines, hybrid machines (2,800 kN) used in the production of thin-walled containers, buckets, lids, etc.

Various governments provide subsidies for healthcare equipment and funding for research into medical devices as part of efforts to support healthcare expansion. The US government, for instance, has long invested significantly in healthcare infrastructure, including funding for medical device research and development. These investments have driven innovation, increasing demand for advanced medical devices and fostering improvements in manufacturing technologies such as precision moulding. In August 2023, DuPont, a US-based company providing technology-based materials and solutions, acquired Spectrum Plastics Group for USD 1.75 billion. This acquisition strengthens DuPont's global presence and medical device portfolio while significantly enhancing its medical injection moulding capabilities.
The adoption of micro-moulding technologies has enabled the creation of highly precise and miniature parts, which are vital for the development of modern medical devices. At the same time, there is a growing trend toward using bio-based materials to meet the increasing demand for environmentally sustainable and safe medical products. Companies such as Accumold, MTD Micro Moulding, and Makuta Technics highly focus on bolstering their micro-moulding capabilities, enhancing their production processes to cater to the need for small, complex medical components. These companies continue to innovate and optimize their manufacturing methods to deliver parts with exceptional precision. Similarly, firms such as DuPont and Cavestro are at the forefront of advancements in bio-based materials, which is evident through the launch of bio-based Tyvek and bio-based polycarbonate, respectively. Both companies are committed to offering more sustainable solutions, ensuring that the materials used in medical devices are both high-performing and environmentally friendly.

North America Medical Injection Molding Market Country Insights

By country, the North America Medical Injection Molding Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

In the US, the expansion of the medical injection moulding market is driven by the growing demand for medical devices and components, which are essential for diagnosing, treating, and monitoring various health conditions. The aging population and the rising incidence of diabetes, cardiovascular diseases (CVDs), respiratory disorders, and other chronic conditions are the main factors driving the demand for medical devices in the country. The Centers for Disease Control and Prevention (CDC) reports that approximately 60% American adults in the country suffer from at least 1 chronic disease, while ~40% adults have two or more. Such elevated incidence rates of chronic diseases result in the need for various medical devices and components in disease management. According to the CDC's National Diabetes Statistics Report for 2022, ~37.3 million Americans were living with diabetes as of 2022; this has led to a higher demand for insulin delivery devices, such as pens and syringes, which are often produced using medical injection moulding techniques. Medical injection moulding is employed in the manufacturing process to produce precise and complex components essential for various medical applications. This process is particularly valuable for creating single-use medical devices.
Milacron, LLC, one of the key players in the US medical injection moulding market, has a diverse product lineup that includes injection moulding machines, extrusion and blow moulding equipment, and hot runner systems. In addition to these offerings, the company provides mold bases and components, process control systems, and MRO supplies for fluid technology and plastic processing equipment. With clamp capacities ranging from 17 to 7,650 tons, the machines can produce an array of items, from precise medical components to large structural plastic products. Additionally, the increasing adoption of single-use medical devices for infection control has further driven the demand for injection-molded components.

North America Medical Injection Molding Market Company Profiles

Some of the key players operating in the market include Biomerics LLC, Ensinger, Aberdeen Technologies, Inc., Husky Technologies, The Rodon Group, Kaysun Corporation, UPG International, C&J Industries, Sanner GmbH, Feronyl, HTI Plastics, Tessy Plastics, and Proto Labs.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Medical Injection Molding Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise